This research report provides a comprehensive analysis of the Biologics Clinical Manufacturing CDMO Service market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Biologics Clinical Manufacturing CDMO Service market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Biologics Clinical Manufacturing CDMO Service, challenges faced by the industry, and potential opportunities for market players.
The global Biologics Clinical Manufacturing CDMO Service market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Biologics Clinical Manufacturing CDMO Service market presents opportunities for various stakeholders, including Big Pharmaceutical Companies, Small and Medium Pharmaceutical Companies. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Biologics Clinical Manufacturing CDMO Service market. Additionally, the growing consumer demand present avenues for market expansion.
The global Biologics Clinical Manufacturing CDMO Service market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Biologics Clinical Manufacturing CDMO Service market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Biologics Clinical Manufacturing CDMO Service market.
Market Overview: The report provides a comprehensive overview of the Biologics Clinical Manufacturing CDMO Service market, including its definition, historical development, and current market size. It covers Market Segmentation by Type (e.g., Traditional API CDMO, Highly Potent API CDMO), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Biologics Clinical Manufacturing CDMO Service market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Biologics Clinical Manufacturing CDMO Service market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Biologics Clinical Manufacturing CDMO Service market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Biologics Clinical Manufacturing CDMO Service market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Biologics Clinical Manufacturing CDMO Service market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Biologics Clinical Manufacturing CDMO Service market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Biologics Clinical Manufacturing CDMO Service, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Biologics Clinical Manufacturing CDMO Service market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Biologics Clinical Manufacturing CDMO Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Traditional API CDMO
- Highly Potent API CDMO
Market segment by Application
- Big Pharmaceutical Companies
- Small and Medium Pharmaceutical Companies
Global Biologics Clinical Manufacturing CDMO Service Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Major players covered
- Thermo Fisher Scientific
- Lonza
- Intertek
- Charles River Laboratories
- Bio-Rad
- Element
- ProPharma
- Ascendia
- Minaris Regenerative Medicine
- TriLink BioTechnologies
- Oakwood Labs
- PiramalPharma Solutions
- Boehringer-Ingelheim
- Wuxi Apptec
- Pharmaron Beijing
- Asymchem Laboratories (Tianjin)
- Porton
- SEQENS
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biologics Clinical Manufacturing CDMO Service, market overview.
Chapter 2: Global Biologics Clinical Manufacturing CDMO Service market size in revenue.
Chapter 3: Detailed analysis of Biologics Clinical Manufacturing CDMO Service company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biologics Clinical Manufacturing CDMO Service in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Biologics Clinical Manufacturing CDMO Service Market, Global Outlook and Forecast 2023-2029
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Biologics Clinical Manufacturing CDMO Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biologics Clinical Manufacturing CDMO Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biologics Clinical Manufacturing CDMO Service Overall Market Size
2.1 Global Biologics Clinical Manufacturing CDMO Service Market Size: 2022 VS 2029
2.2 Global Biologics Clinical Manufacturing CDMO Service Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biologics Clinical Manufacturing CDMO Service Players in Global Market
3.2 Top Global Biologics Clinical Manufacturing CDMO Service Companies Ranked by Revenue
3.3 Global Biologics Clinical Manufacturing CDMO Service Revenue by Companies
3.4 Top 3 and Top 5 Biologics Clinical Manufacturing CDMO Service Companies in Global Market, by Revenue in 2022
3.5 Global Companies Biologics Clinical Manufacturing CDMO Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biologics Clinical Manufacturing CDMO Service Players in Global Market
3.6.1 List of Global Tier 1 Biologics Clinical Manufacturing CDMO Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Biologics Clinical Manufacturing CDMO Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Biologics Clinical Manufacturing CDMO Service Market Size Markets, 2022 & 2029
4.1.2 Traditional API CDMO
4.1.3 Highly Potent API CDMO
4.2 By Type - Global Biologics Clinical Manufacturing CDMO Service Revenue & Forecasts
4.2.1 By Type - Global Biologics Clinical Manufacturing CDMO Service Revenue, 2018-2023
4.2.2 By Type - Global Biologics Clinical Manufacturing CDMO Service Revenue, 2024-2029
4.2.3 By Type - Global Biologics Clinical Manufacturing CDMO Service Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biologics Clinical Manufacturing CDMO Service Market Size, 2022 & 2029
5.1.2 Big Pharmaceutical Companies
5.1.3 Small and Medium Pharmaceutical Companies
5.2 By Application - Global Biologics Clinical Manufacturing CDMO Service Revenue & Forecasts
5.2.1 By Application - Global Biologics Clinical Manufacturing CDMO Service Revenue, 2018-2023
5.2.2 By Application - Global Biologics Clinical Manufacturing CDMO Service Revenue, 2024-2029
5.2.3 By Application - Global Biologics Clinical Manufacturing CDMO Service Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Biologics Clinical Manufacturing CDMO Service Market Size, 2022 & 2029
6.2 By Region - Global Biologics Clinical Manufacturing CDMO Service Revenue & Forecasts
6.2.1 By Region - Global Biologics Clinical Manufacturing CDMO Service Revenue, 2018-2023
6.2.2 By Region - Global Biologics Clinical Manufacturing CDMO Service Revenue, 2024-2029
6.2.3 By Region - Global Biologics Clinical Manufacturing CDMO Service Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Biologics Clinical Manufacturing CDMO Service Revenue, 2018-2029
6.3.2 US Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.3.3 Canada Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.3.4 Mexico Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Biologics Clinical Manufacturing CDMO Service Revenue, 2018-2029
6.4.2 Germany Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.4.3 France Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.4.4 U.K. Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.4.5 Italy Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.4.6 Russia Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.4.7 Nordic Countries Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.4.8 Benelux Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Biologics Clinical Manufacturing CDMO Service Revenue, 2018-2029
6.5.2 China Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.5.3 Japan Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.5.4 South Korea Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.5.5 Southeast Asia Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.5.6 India Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Biologics Clinical Manufacturing CDMO Service Revenue, 2018-2029
6.6.2 Brazil Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.6.3 Argentina Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biologics Clinical Manufacturing CDMO Service Revenue, 2018-2029
6.7.2 Turkey Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.7.3 Israel Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.7.4 Saudi Arabia Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
6.7.5 UAE Biologics Clinical Manufacturing CDMO Service Market Size, 2018-2029
7 Biologics Clinical Manufacturing CDMO Service Companies Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.1.4 Thermo Fisher Scientific Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.1.5 Thermo Fisher Scientific Key News & Latest Developments
7.2 Lonza
7.2.1 Lonza Company Summary
7.2.2 Lonza Business Overview
7.2.3 Lonza Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.2.4 Lonza Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.2.5 Lonza Key News & Latest Developments
7.3 Intertek
7.3.1 Intertek Company Summary
7.3.2 Intertek Business Overview
7.3.3 Intertek Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.3.4 Intertek Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.3.5 Intertek Key News & Latest Developments
7.4 Charles River Laboratories
7.4.1 Charles River Laboratories Company Summary
7.4.2 Charles River Laboratories Business Overview
7.4.3 Charles River Laboratories Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.4.4 Charles River Laboratories Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.4.5 Charles River Laboratories Key News & Latest Developments
7.5 Bio-Rad
7.5.1 Bio-Rad Company Summary
7.5.2 Bio-Rad Business Overview
7.5.3 Bio-Rad Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.5.4 Bio-Rad Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.5.5 Bio-Rad Key News & Latest Developments
7.6 Element
7.6.1 Element Company Summary
7.6.2 Element Business Overview
7.6.3 Element Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.6.4 Element Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.6.5 Element Key News & Latest Developments
7.7 ProPharma
7.7.1 ProPharma Company Summary
7.7.2 ProPharma Business Overview
7.7.3 ProPharma Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.7.4 ProPharma Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.7.5 ProPharma Key News & Latest Developments
7.8 Ascendia
7.8.1 Ascendia Company Summary
7.8.2 Ascendia Business Overview
7.8.3 Ascendia Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.8.4 Ascendia Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.8.5 Ascendia Key News & Latest Developments
7.9 Minaris Regenerative Medicine
7.9.1 Minaris Regenerative Medicine Company Summary
7.9.2 Minaris Regenerative Medicine Business Overview
7.9.3 Minaris Regenerative Medicine Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.9.4 Minaris Regenerative Medicine Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.9.5 Minaris Regenerative Medicine Key News & Latest Developments
7.10 TriLink BioTechnologies
7.10.1 TriLink BioTechnologies Company Summary
7.10.2 TriLink BioTechnologies Business Overview
7.10.3 TriLink BioTechnologies Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.10.4 TriLink BioTechnologies Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.10.5 TriLink BioTechnologies Key News & Latest Developments
7.11 Oakwood Labs
7.11.1 Oakwood Labs Company Summary
7.11.2 Oakwood Labs Business Overview
7.11.3 Oakwood Labs Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.11.4 Oakwood Labs Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.11.5 Oakwood Labs Key News & Latest Developments
7.12 PiramalPharma Solutions
7.12.1 PiramalPharma Solutions Company Summary
7.12.2 PiramalPharma Solutions Business Overview
7.12.3 PiramalPharma Solutions Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.12.4 PiramalPharma Solutions Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.12.5 PiramalPharma Solutions Key News & Latest Developments
7.13 Boehringer-Ingelheim
7.13.1 Boehringer-Ingelheim Company Summary
7.13.2 Boehringer-Ingelheim Business Overview
7.13.3 Boehringer-Ingelheim Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.13.4 Boehringer-Ingelheim Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.13.5 Boehringer-Ingelheim Key News & Latest Developments
7.14 Wuxi Apptec
7.14.1 Wuxi Apptec Company Summary
7.14.2 Wuxi Apptec Business Overview
7.14.3 Wuxi Apptec Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.14.4 Wuxi Apptec Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.14.5 Wuxi Apptec Key News & Latest Developments
7.15 Pharmaron Beijing
7.15.1 Pharmaron Beijing Company Summary
7.15.2 Pharmaron Beijing Business Overview
7.15.3 Pharmaron Beijing Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.15.4 Pharmaron Beijing Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.15.5 Pharmaron Beijing Key News & Latest Developments
7.16 Asymchem Laboratories (Tianjin)
7.16.1 Asymchem Laboratories (Tianjin) Company Summary
7.16.2 Asymchem Laboratories (Tianjin) Business Overview
7.16.3 Asymchem Laboratories (Tianjin) Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.16.4 Asymchem Laboratories (Tianjin) Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.16.5 Asymchem Laboratories (Tianjin) Key News & Latest Developments
7.17 Porton
7.17.1 Porton Company Summary
7.17.2 Porton Business Overview
7.17.3 Porton Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.17.4 Porton Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.17.5 Porton Key News & Latest Developments
7.18 SEQENS
7.18.1 SEQENS Company Summary
7.18.2 SEQENS Business Overview
7.18.3 SEQENS Biologics Clinical Manufacturing CDMO Service Major Product Offerings
7.18.4 SEQENS Biologics Clinical Manufacturing CDMO Service Revenue in Global Market (2018-2023)
7.18.5 SEQENS Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Biologics Clinical Manufacturing CDMO Service Market Opportunities & Trends in Global Market
Table 2. Biologics Clinical Manufacturing CDMO Service Market Drivers in Global Market
Table 3. Biologics Clinical Manufacturing CDMO Service Market Restraints in Global Market
Table 4. Key Players of Biologics Clinical Manufacturing CDMO Service in Global Market
Table 5. Top Biologics Clinical Manufacturing CDMO Service Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Biologics Clinical Manufacturing CDMO Service Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Biologics Clinical Manufacturing CDMO Service Revenue Share by Companies, 2018-2023
Table 8. Global Companies Biologics Clinical Manufacturing CDMO Service Product Type
Table 9. List of Global Tier 1 Biologics Clinical Manufacturing CDMO Service Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biologics Clinical Manufacturing CDMO Service Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Biologics Clinical Manufacturing CDMO Service Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Biologics Clinical Manufacturing CDMO Service Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application - Global Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Biologics Clinical Manufacturing CDMO Service Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Biologics Clinical Manufacturing CDMO Service Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region - Global Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2024-2029
Table 30. Thermo Fisher Scientific Company Summary
Table 31. Thermo Fisher Scientific Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 32. Thermo Fisher Scientific Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 33. Thermo Fisher Scientific Key News & Latest Developments
Table 34. Lonza Company Summary
Table 35. Lonza Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 36. Lonza Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 37. Lonza Key News & Latest Developments
Table 38. Intertek Company Summary
Table 39. Intertek Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 40. Intertek Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 41. Intertek Key News & Latest Developments
Table 42. Charles River Laboratories Company Summary
Table 43. Charles River Laboratories Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 44. Charles River Laboratories Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 45. Charles River Laboratories Key News & Latest Developments
Table 46. Bio-Rad Company Summary
Table 47. Bio-Rad Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 48. Bio-Rad Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 49. Bio-Rad Key News & Latest Developments
Table 50. Element Company Summary
Table 51. Element Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 52. Element Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 53. Element Key News & Latest Developments
Table 54. ProPharma Company Summary
Table 55. ProPharma Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 56. ProPharma Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 57. ProPharma Key News & Latest Developments
Table 58. Ascendia Company Summary
Table 59. Ascendia Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 60. Ascendia Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 61. Ascendia Key News & Latest Developments
Table 62. Minaris Regenerative Medicine Company Summary
Table 63. Minaris Regenerative Medicine Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 64. Minaris Regenerative Medicine Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 65. Minaris Regenerative Medicine Key News & Latest Developments
Table 66. TriLink BioTechnologies Company Summary
Table 67. TriLink BioTechnologies Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 68. TriLink BioTechnologies Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 69. TriLink BioTechnologies Key News & Latest Developments
Table 70. Oakwood Labs Company Summary
Table 71. Oakwood Labs Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 72. Oakwood Labs Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 73. Oakwood Labs Key News & Latest Developments
Table 74. PiramalPharma Solutions Company Summary
Table 75. PiramalPharma Solutions Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 76. PiramalPharma Solutions Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 77. PiramalPharma Solutions Key News & Latest Developments
Table 78. Boehringer-Ingelheim Company Summary
Table 79. Boehringer-Ingelheim Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 80. Boehringer-Ingelheim Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 81. Boehringer-Ingelheim Key News & Latest Developments
Table 82. Wuxi Apptec Company Summary
Table 83. Wuxi Apptec Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 84. Wuxi Apptec Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 85. Wuxi Apptec Key News & Latest Developments
Table 86. Pharmaron Beijing Company Summary
Table 87. Pharmaron Beijing Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 88. Pharmaron Beijing Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 89. Pharmaron Beijing Key News & Latest Developments
Table 90. Asymchem Laboratories (Tianjin) Company Summary
Table 91. Asymchem Laboratories (Tianjin) Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 92. Asymchem Laboratories (Tianjin) Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 93. Asymchem Laboratories (Tianjin) Key News & Latest Developments
Table 94. Porton Company Summary
Table 95. Porton Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 96. Porton Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 97. Porton Key News & Latest Developments
Table 98. SEQENS Company Summary
Table 99. SEQENS Biologics Clinical Manufacturing CDMO Service Product Offerings
Table 100. SEQENS Biologics Clinical Manufacturing CDMO Service Revenue (US$, Mn) & (2018-2023)
Table 101. SEQENS Key News & Latest Developments
List of Figures
Figure 1. Biologics Clinical Manufacturing CDMO Service Segment by Type in 2022
Figure 2. Biologics Clinical Manufacturing CDMO Service Segment by Application in 2022
Figure 3. Global Biologics Clinical Manufacturing CDMO Service Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biologics Clinical Manufacturing CDMO Service Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biologics Clinical Manufacturing CDMO Service Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biologics Clinical Manufacturing CDMO Service Revenue in 2022
Figure 8. By Type - Global Biologics Clinical Manufacturing CDMO Service Revenue Market Share, 2018-2029
Figure 9. By Application - Global Biologics Clinical Manufacturing CDMO Service Revenue Market Share, 2018-2029
Figure 10. By Type - Global Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Biologics Clinical Manufacturing CDMO Service Revenue Market Share, 2018-2029
Figure 12. By Application - Global Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Biologics Clinical Manufacturing CDMO Service Revenue Market Share, 2018-2029
Figure 14. By Region - Global Biologics Clinical Manufacturing CDMO Service Revenue Market Share, 2018-2029
Figure 15. By Country - North America Biologics Clinical Manufacturing CDMO Service Revenue Market Share, 2018-2029
Figure 16. US Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Biologics Clinical Manufacturing CDMO Service Revenue Market Share, 2018-2029
Figure 20. Germany Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 21. France Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Biologics Clinical Manufacturing CDMO Service Revenue Market Share, 2018-2029
Figure 28. China Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 32. India Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Biologics Clinical Manufacturing CDMO Service Revenue Market Share, 2018-2029
Figure 34. Brazil Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Biologics Clinical Manufacturing CDMO Service Revenue Market Share, 2018-2029
Figure 37. Turkey Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Biologics Clinical Manufacturing CDMO Service Revenue, (US$, Mn), 2018-2029
Figure 41. Thermo Fisher Scientific Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Lonza Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Intertek Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Charles River Laboratories Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bio-Rad Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Element Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. ProPharma Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Ascendia Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Minaris Regenerative Medicine Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. TriLink BioTechnologies Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Oakwood Labs Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. PiramalPharma Solutions Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Boehringer-Ingelheim Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Wuxi Apptec Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Pharmaron Beijing Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Asymchem Laboratories (Tianjin) Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Porton Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. SEQENS Biologics Clinical Manufacturing CDMO Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Global Public and Personal Safety Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
Published: 11-Jan-2024 Price: US 5600 Onwards Pages: 177
The global Public and Personal Safety Industry market size was US$ 6,398.95 million in 2022 and is forecast to a readjusted size of US$ 18,265.36 million by 2029 with a CAGR of 16.88% during the forecast period 2023-2029.
The global key companies of Public and Personal Safety Industry include Hexagon, Motorola Solutions Inc, NEC, Tyler Technologies Inc and Indra Sistemas, accounting for 24.50% market share in terms of revenues in 2022.
The market research report offered here is a v......
Global Digital Watermark Technology Market Report, History and Forecast 2018-2029
Published: 11-Jan-2024 Price: US 3350 Onwards Pages: 118
The global market for Digital Watermark Technology estimated was at US$ 111.3 million in the year 2022, is projected to reach a revised size of US$ 210.53 million by 2029, growing at a CAGR of 9.4% during the forecast period 2023-2029.
North American market for Digital Watermark Technology was valued at $ 39.07 million in 2022 and will reach $ 68.79 million by 2029, at a CAGR of 8.2 % during the forecast period of 2023 through 2029.
Asia-Pacific market for Digital Watermark Technol......
Global Location Based Marketing Services Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 74
The global Location Based Marketing Services market was valued at US$ 46700 million in 2023 and is anticipated to reach US$ 144870 million by 2030, witnessing a CAGR of 17.2% during The forecast period 2024-2030.
North American market for Location Based Marketing Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Location Based Marketing Services is estima......
Global Auto Repair and Beauty Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 72
The global Auto Repair and Beauty market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
Automotive is a key driver of this industry. According to data from The World Automobile Organization (OICA), global automobile production and sales in 2017 reached their peak in The past 10 years, at 97.3 million and 95.89 million respectively. In 2018, The global economic expansion ended, and The gl......
Global Viral Vector Development Service Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 77
The global Viral Vector Development Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Viral Vector Development Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Viral Vector Development Service is estimated to increase from......
Global Building Automation Systems (BAS) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Building Automation Systems (BAS) market was valued at US$ 75680 million in 2023 and is anticipated to reach US$ 143970 million by 2030, witnessing a CAGR of 9.5% during The forecast period 2024-2030.
North American market for Building Automation Systems (BAS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Building Automation Systems (BAS) is estimat......
Global SLAM in Mobile Robots and Smart AR Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 92
This report studies The SLAM Robots market, Simultaneous localization and mapping, or SLAM for short, is The process of creating a map using a robot or unmanned vehicle that navigates that environment while using The map it generates. SLAM is technique behind robot mapping or robotic cartography. The robot or vehicle plots a course in an area, but at The same time, it also has to figure out where its own self is located in The place. The process of SLAM uses a complex array of computations, algo......
Global Digital Educational Publishing Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 90
The global Digital Educational Publishing market was valued at US$ 8324.5 million in 2023 and is anticipated to reach US$ 14580 million by 2030, witnessing a CAGR of 7.9% during The forecast period 2024-2030.
North American market for Digital Educational Publishing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Digital Educational Publishing is estimated to inc......
Global Human Source Service Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 70
The global Human Source Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Human Source Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Human Source Service is estimated to increase from $ million in 2023 to reach $ millio......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
